This inventor holds 5 USPTO granted patents. Top assignee: Cold Spring Harbor Laboratory. Active years: 2002-2005.
Company Filing History:
Years Active: 2002-2005
Title: Innovations and Contributions of Hollis Cline
Introduction
Hollis Cline is a notable inventor based in Cold Spring Harbor, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of nitric oxide inhibitors and single-cell electroporation. With a total of 5 patents, Cline's work has the potential to impact various therapeutic applications.
Latest Patents
Cline's latest patents include innovative methods for therapeutic uses of nitric oxide inhibitors. His research indicates that nitric oxide (NO) plays a crucial role as a growth regulator in developing organisms. One of his inventions focuses on increasing the population of hematopoietic stem cells in mammals by using inhibitors of nitric oxide synthase (NOS). This method aims to enhance normal hematopoiesis, differentiation, and maturation in hematopoietic tissue. Additionally, he has developed a technique for regenerating tissue in adult mammals by inhibiting differentiation and promoting cell proliferation through the application of NO inhibitors. Another significant patent involves a single-cell electroporation assembly that allows for the delivery of substances into individual cells. This method utilizes electrical pulses to create temporary pores in cell membranes, facilitating the entry of substances through passive diffusion or active electrophoretic motion.
Career Highlights
Cline is affiliated with the Cold Spring Harbor Laboratory, where he conducts his research and develops his inventions. His work has garnered attention for its potential applications in regenerative medicine and cellular biology.
Collaborations
Cline has collaborated with esteemed colleagues such as Grigori N Enikolopov and Natalia I Peunova, contributing to a rich environment of scientific inquiry and innovation.
Conclusion
Hollis Cline's contributions to the field of biomedical research through his patents and collaborations highlight his role as a significant inventor. His innovative approaches to nitric oxide inhibitors and single-cell electroporation are paving the way for advancements in therapeutic applications.